Skip to content

Clinical trials

Completed Rare Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Rare Diseases Status: Completed Clear all

352 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200021
20014
20032
20041
20064
20071
20093
20102
20111
20122
20136
20143
20153
20164
20173
20185
20197
20207
20217
20223
20235
20248
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed352

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Center for Research Resources (NCRR)133
FDA Office of Orphan Products Development19
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)10
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)9
National Institute of Neurological Disorders and Stroke (NINDS)8
Icahn School of Medicine at Mount Sinai6
National Institute of Allergy and Infectious Diseases (NIAID)6
Amgen5
Ultragenyx Pharmaceutical Inc5
Children's Hospital Medical Center, Cincinnati4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Rare Diseases352
Genetic Diseases, Inborn58
Mental Disorders56
Neurologic Manifestations56
Respiratory Tract Diseases40
Communicable Diseases39
Immune System Diseases39
Metabolism, Inborn Errors31
Endocrine System Diseases28
Hematologic Diseases27

Trials

Showing 26 to 50 of 352. Each trial links to its page on Pharma Observatory.

252 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.